Literature DB >> 3143238

Intraarterial digital subtraction angiography for definitive diagnosis of intracranial aneurysms.

H Touho1, J Karasawa, T Tazawa, J Nakagawara, K Yamada, K Kobayashi, M Asai, M Kagawa, H Yasue.   

Abstract

Comparisons between digital subtraction angiography and conventional angiography have frequently been made in the radiologic literature, and the high quality and several advantages of the former have been reported. In this study, 101 patients with intracranial aneurysms were examined only by intraarterial digital subtraction angiography; no conventional angiography was used. High-quality images were consistently obtained, facilitating an accurate and definitive diagnosis of intracranial aneurysm. Magnification radiography and stereography using intraarterial digital subtraction angiography were done to obtain a more precise diagnosis. Five small intracranial aneurysms with diameters of 1.0 to 2.0 mm could be detected. The procedure was considered to be as reliable and as safe as conventional angiography, used previously. Important advantages of intraarterial digital subtraction angiography include reduced procedural time and decreased contrast agent burden, factors that will ensure broader application of this procedure for definitive diagnosis of intracranial aneurysms as experience with the technique accumulates.

Entities:  

Mesh:

Year:  1988        PMID: 3143238      PMCID: PMC8331903     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

1.  Selective cerebral intraarterial DSA. Complication rate and control of risk factors.

Authors:  U Grzyska; J Freitag; H Zeumer
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Automated highly multiplexed super-resolution imaging of protein nano-architecture in cells and tissues.

Authors:  Maja Klevanski; Frank Herrmannsdoerfer; Steffen Sass; Varun Venkataramani; Mike Heilemann; Thomas Kuner
Journal:  Nat Commun       Date:  2020-03-25       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.